Do thiazide diuretics cause hyponatremia?

Thiazide diuretics are widely used for hypertension and fluid management, but they carry a distinct risk of causing electrolyte disturbances, particularly hyponatremia. This risk is heavily pronounced in older adults, such as a 68-year-old male, due to age-related physiological changes in renal function and fluid balance.

Pathophysiologic mechanisms

• Impaired urinary dilution: Thiazides selectively block the $Na^+/Cl^-$ cotransporter (NCC) in the distal convoluted tubule, which serves as the kidney's primary diluting segment. By inhibiting solute reabsorption at this site, these agents directly prevent the generation of dilute urine and limit the capacity for renal free water clearance.
• Volume depletion and AVP release: The resulting renal sodium and chloride wasting leads to mild extracellular volume depletion. This state stimulates non-osmotic vasopressin (AVP) secretion and triggers thirst, leading to enhanced water intake and increased water reabsorption in the collecting ducts, causing dilutional hyponatremia.
• Intracellular cation shifts: Concomitant potassium depletion (hypokalemia) induced by thiazides worsens hyponatremia. As intracellular potassium is lost, sodium shifts into cells to maintain electrical neutrality and osmotic balance, further lowering extracellular and serum sodium levels.

Clinical risk and monitoring

• Age-related vulnerability: Patients over 65 years of age face a significantly higher risk of severe thiazide-induced hyponatremia (often defined as serum sodium $< 130 \text{ mEq/L}$) due to a baseline reduction in glomerular filtration rate (GFR) and altered osmoregulation.
• Monitoring timeline: Because most cases of severe hyponatremia develop within 2 to 4 weeks of treatment initiation or dose escalation, close laboratory monitoring of serum electrolytes (sodium and potassium) is highly recommended during this initial window for older male patients.

Bottom line

• Thiazide diuretics cause hyponatremia via a dual mechanism of impaired urinary dilution and renal sodium wasting, a risk that is critically elevated in older patients (such as a 68-year-old male) and exacerbated by concurrent potassium depletion. Careful electrolyte monitoring is essential during the initiation of therapy.